Gravier Pierre bought PTCT
February 15, 2024 · Form 4 insider transaction
Gravier Pierre bought 19,000 shares of PTC Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
19,000
Price
$0.00
Total value
N/A
InsiderGravier Pierre
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 15, 2024
Filing dateFebruary 16, 2024
Shares owned after52,700
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Restricted stock units granted on February 15, 2024 that vest in four equal installments over four years, commencing on February 15, 2025.